Connect with us

Cannabis

“NEXT SUPER STOCKS” on the move: CEO’s of WEYL, DOCRF, NEXCF, PMEDF discuss latest advances in Telemedicine, E-Commerce, AI, AR & Healthtech

GlobeNewswire

Published

on

NEW YORK, Aug. 18, 2020 (GLOBE NEWSWIRE) — Wall Street Reporter, the trusted name in financial news since 1843, is highlighting CEO comments and latest news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK livestream investor conferences, and investor “LiveChats”. More than 11,000 self-directed and institutional investors have participated in the NEXT SUPER STOCK livestreams in recent weeks.

NexTech AR Solutions (OTC: NEXCF) (CSE: NTAR): “Now Positioned for Exponential E-Commerce Revenue Growth, with Major Brand Expansion”
Video: https://bit.ly/3ggoWP7

CloudMD (OTC: DOCRF): “The Future of Telemedicine”
Video: https://bit.ly/2Ycgv0J

Weyland Tech (OTC: WEYL) “’The Shopify of Mobile in SE Asia’ w $40+ mil revenues”
Video: https://bit.ly/3g9H0Km

Predictmedix, Inc. (OTC: PMEDF) (CSE: PMED) “Predictmedix at Forefront of $300 Billion Healthtech Wave”
Video:  https://bit.ly/3g9G4WC

Highlights CEO comments from latest NEXT SUPER STOCK livestreams and investor conferences:

Weyland Tech (OTC: WEYL) “’The Shopify of Mobile in SE Asia’ w $40+ mil revenues”

Weyland Tech (OTC: WEYL) CEO Brent Suen recently spoke with investors about WEYL’s latest developments, including the acquisition of an AI technology company, accelerating revenue growth, new fintech partnerships in the booming Indonesia market, and plans for NASDAQ uplisting. Brent also explained why WEYL has compelling upside, when comparing valuation multiples, which is just a fraction of it’s peers in the e-commerce/fintech space such as SHOP, SE, STNE, and JMIA, which trade at 30X revenues.

Latest WEYL news:

  • August 14 WEYL reported a 30% increase in revenues to $9.3 million.
  • August 13 WEYL announced the acquisition of Fixel AI, an innovator in AI-powered digital marketing technology. Fixel AI helps e-commerce companies improve profits by segmenting and ranking website visitors based on their level of engagement.
  • July 27, WEYL announced a new partnership with ShopeePay, the mobile e-wallet platform of Sea Limited, to launch a marketing campaign for Weyland’s fast-growing AtozGo(TM) food delivery service in Jakarta, Indonesia. ShopeePay will offer the AtozGo food and grocery delivery service to its large and growing fintech user base in Jakarta. Through this integration, AtozGo will gain access to the hundreds of thousands of merchants and millions of users already on the ShopeePay fintech platform. Indonesia’s Internet economy was worth $40 billion in 2019 and will grow more than threefold by 2025 (e-Conomy SEA 2019 report by Google, Temasek, and Bain). Weyland’s success with AtozGo and ShopeePay has validated Weyland’s entry into Indonesia as one of only a handful of U.S. publicly traded companies focused on this hyper-growth emerging market.

Watch WEYL Next Super Stock livestream video: https://bit.ly/3g9H0Km

Click here to join August 20 NEXT SUPER STOCK livestream: https://bit.ly/2PX0SpH

CloudMD (OTC: DOCRF): “The Future of Telemedicine”

CloudMD (OTC: DOCRF) (TSX.V:DOC) CEO Dr. Essam Hamza, M.D. recently shared with Wall Street Reporter’s investor audiences how CloudMD is addressing a multi-billion dollar market opportunity by digitizing the delivery of healthcare – providing patients access to all points of their care from their phone, tablet or desktop computer.

Click here to watch DOCRF livestream investor chat’s and NEXT SUPER STOCK conference video: https://bit.ly/2Ycgv0J

CloudMD offers SaaS based health technology solutions to medical clinics and healthcare providers across North America and has developed proprietary technology that delivers quality healthcare through the combination of connected primary care clinics, telemedicine, and artificial intelligence (AI). CloudMD currently provides service to a combined ecosystem of 376 clinics, over 3000 licensed practitioners and almost 3 million patient charts across its servers.

Latest DOCRF News:

August 13 – DOCRF is acquiring majority interest in West Mississauga Medical Clinic a comprehensive family medicine and specialist medical clinic serving over 100,000 patients, securing footprint in Ontario with cash flow positive clinic, with revenue of C$1.8 million in 2019.

August 6 – DOCRF continues US expansion with an acquisition of a chronic care medical clinic in Mississippi, as a part of its broader strategy for entering the U.S. market with its comprehensive suite of telehealth products. This clinic will power a network of telehealth powered satellite clinics covering large areas of underserviced areas across the U.S.

July 28 – CloudMD announced signing a definitive agreement to acquire South Surrey Medical Clinic, a premier provider of integrated medical solutions and an early adopter of telemedicine delivery. The Clinic has been able to streamline healthcare services and provide longitudinal and team-based patient centric care by offering a number of medical services from one location. The clinic operates with 24 healthcare professionals, including, 12 physicians across various specialities including mental health, women’s health, sports medicine, gynecology and psychiatry. South Surrey services over 60,000 patients and already uses online booking, EMR software and telemedicine that will be easily integrated into CloudMD’s software and clinic network.

WATCH CloudMD NEXT SUPER STOCK livestream video: https://bit.ly/2Ycgv0J

Click here to join August 20 NEXT SUPER STOCK livestream: https://bit.ly/2PX0SpH

NexTech AR Solutions (OTC: NEXCF) (CSE: NTAR) CEO Evan Gappelberg: “Now Positioned for Exponential E-Commerce Revenue Growth, with Major Brand Expansion”

NexTech has been making news recently with explosive growth in it’s AR-powered video conference solutions for global enterprise, and EdTech. (The global virtual events market in 2020 is $90 billion and expected to reach more than $400 billion by 2027, according to Grandview Research).  Not to be overlooked is NEXCF’s substantial e-commerce business which utilizes Augmented Reality solutions to optimize customer experiences, and selling rates.

Click here to watch August 18 CEO livestream/investor chat as NEXCF CEO Evan Gappelberg discusses scaling e-commerce revenue: https://bit.ly/3ggoWP7

On July 17, NEXCF announced a major product line expansion which takes it from selling just one major brand – Miele – to now adding seven consumer brands, including, Dyson, Philips Norelco, MR. Coffee, VitaMix, Breville and Cuisinart. These new distribution deals position the company to take full advantage of the new SFH (shop from home) paradigm shift in e-commerce as well as leverage its full augmented reality technology stack into these brands, which includes its WebAR, ARitize360 app and it’s 3D/AR advertising network. The company expects these new products to have a significant impact on future revenues. Evan Gappelberg, Chief Executive Officer, NexTech AR noted “Up until 60 days, Miele accounted for the majority of our AR ecommerce business. Now with seven major new brands and more in the works, we are exponentially increasing our AR e-commerce revenue potential.”

WATCH NexTechAR (OTC: NEXCF) (CSE: NTAR) NEXT SUPER STOCK Conference Video at: https://bit.ly/3ggoWP7

July 30 –  NEXCF announced a new contract with Ryerson University to provide InfernoAR Augmented Reality Remote Learning Solutions, with an initial focus on first year Chemistry, Biology and Physics students from the Faculty of Science at Ryerson and enable over 5,000 students to participate in rich, collaborative AR enhanced learning experiences during the Fall and Winter Terms. Ryerson University of Toronto, Canada has over 46,000 students.

July 27 – NEXCF announced that it has priced its prospectus offering, raising up to C$15,000,000. The offering will be conducted on an agency basis for the issuance of up to 2,307,692 units of the Company at a price of C$6.50 per Unit. The units consist of one share of common stock, and a half warrant exercisable at C$8.00. The Offering is being led by Mackie Research Capital Corporation as sole agent and sole bookrunner.

July 22 – NEXCF reported preliminary Q2 2020 results: Revenue increases +133% to $3.5 million. Gross Profit increases +171% to $2.1 million with a 60% margin.

July 8 – NEXCF announced it has filed to up-list its shares to NASDAQ.

WATCH NexTechAR (OTC: NEXCF) (CSE: NTAR) NEXT SUPER STOCK Conference Video at: https://bit.ly/3iHXvz4

Click here to join August 20 NEXT SUPER STOCK livestream: https://bit.ly/2PX0SpH

Predictmedix, Inc. (OTC: PMEDF) (CSE: PMED) Dr. Rahul Kushwah, COO: “Predictmedix at Forefront of $300 Billion Healthtech Wave”

Predictmedix (OTC: PMEDF) (CSE: PMED) COO Dr. Rahul Kushwah a featured presenter at Wall Street Reporter’s recent NEXT SUPER STOCK investor conferences, recently updated investors in key new developments.

Click here to watch  PMEDF livestream investor chat’s and NEXT SUPER STOCK conference video: https://bit.ly/3g9G4WC

Topics discussed include:

  • How PMEDF Artificial Intelligence (AI) based technologies can be deployed for mass healthcare screening for infectious diseases, including COVID19.
  • Market potential for global enterprise & agencies deploying PMEDF AI screening technologies for detecting cannabis, alcohol and opioid impairment.
  • Acquisition of Mobile Wellbeing Telehealth platform for remote patient monitoring addressing the $250 billion Virtual Health market opportunity.
  • Patent & technology overview of PMEDF screening technology which combines AI, and multispectral cameras which allows for rapid, non-invasive testing, and scaleable deployment.
  • Strategic partnerships which include Max Healthcare, one of India’s leading providers of comprehensive healthcare services with a network of over 14 hospitals and 2,300 doctors, and Tech Mahindra, a $4.9 billion global IT company. 

Recent PMEDF news:
August 17 – PMEDF announced it is deploying it’s COVID-19 symptom mass screening technology in partnership with Juiceworks Exhibits at two new sites including: Flow Water bottling plant, and a major 24 hour retail pharmacy in Montreal.

August 12 – PMEDF announced deployment of its COVID-19 screening technology along with alcohol and impairment screening technology at Indian Oil Corporation Ltd ((“IOCL”), an Indian Public Sector Undertaking FORTUNE 500 company). Predictmedix COVID-19 screening technology is designed to mass screen for symptomatic individuals to help reduce the risk of transmission in places which have a large movement of people. At the same time, impairment remains to be a massive health and safety issue at the workplace and Predictmedix impairment detection technology is designed to identify alcohol and cannabis impairment. The two Predictmedix technologies will be deployed at Indian Oil Bhawan, New Delhi. The deployment is expected to begin within the next 3-4 weeks.

Watch PMEDF NEXT SUPER STOCK livestream video: https://bit.ly/3g9G4WC

Click here to join August 20 NEXT SUPER STOCK livestream: https://bit.ly/2PX0SpH

About Wall Street Reporter’s Next Super Stock conference:

Wall Street Reporter’s NEXT SUPER STOCK Live! conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead.

Examples of value creation catalysts include: Major new product launches, mergers & acquisitions, new resource discoveries, FDA approvals, and other value creation events – which transform companies and create SUPER STOCKS (with +10X upside potential).

Over the past 20 years, Wall Street Reporter’s investor conferences have earned a unique reputation for showcasing high-potential stocks – many of which go on to deliver triple-digit gains, and become Super Stocks.

Transparency and Open Access: Unlike typical investor conferences which are restricted to institutional investors, or corporate clients – Wall Street Reporter takes pride in giving the investing public free and open online access to the NEXT SUPER STOCK conference. This online event allows retail investors the same level of CEO access and information, which was once restricted to institutional investors, and investment banking clients. Watching this online/livestream event, gives investors an opportunity to get in on the ground floor of what could be the “Next Super Stock” – before they are discovered by Wall Street. https://www.wallstreetreporter.com/next-superstock-online-investor-conference/

Wall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEO’s of promising, publicly-traded companies, and market experts. www.WallStreetReporter.com

CONTACT:

WALL STREET REPORTER

(212) 871-2057 ext 7

www.WallStreetReporter.com

Cannabis

Red Light Holland Reaches Distribution Agreement for iMicrodose Packs Plus Agrees to Build out an iMicrodose Media Information Centre (iMIC) with Super Smart’s Location in Tiel, The Netherlands

Newsfile

Published

on

Toronto, Ontario–(Newsfile Corp. – September 28, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce their iMicrodose Packs (“iMicrodose Packs“) powered by Red Light Holland are expected to be available early October 2020 in PharmaDrug Inc.’s (“PharmaDrug”) wholly-owned subsidiary Interrobang Ltd.’s (doing business as Super Smart) (“Super Smart“) store in Tiel, The Netherlands, as Red Light Holland has reached a distribution agreement with Super Smart.

Red Light Holland has also reached an agreement with Super Smart to build and set up an iMicrodose Media Information Centre (“iMIC“) in Super Smart’s Tiel location, expected to be ready before the end of 2020.

“Super Smart’s vision and iMicrodose’s vision truly align,” said Todd Shapiro, CEO and Director of Red Light Holland. “Both companies are focused on educating, informing and modernizing the psychedelic industry within the Netherlands. We are very excited to soon have another store where our product is sold to expand our exposure and marketplace. Equally as important, we are proud to set up our first iMicrodose Media Information Centre – iMIC – where we plan on eventually providing Super Smart with our Virtual Reality Headset where consumers can truly learn about our iMicrodose packs and the origins of the product, as well as hope to receive important customer feedback, as we want to give all consumers a voice for important information gathering and responsible-use feedback via our planned iMIC activation.”

“Red Light Holland has definitely already taken initial steps to modernize the industry, in the Netherlands, and we are so pleased to reach an agreement to house their responsible use product in our Tiel, Location, expected in Early October, 2020,” added Dan Cohen, CEO of PharmaDrug. “Together we want to elevate the industry, educate consumers and intelligently target all Adult Demographics for potential increased sales via new customers with an informational, technological and modern approach.”

Super Smart’s Tiel location is located in Central Netherlands and is the only smart shop within a 75 kilometre radius. iMicrodose Packs powered by Red Light Holland are expected to be in Smart Shop’s Tiel store in October, 2020.

Cannot view this image? Visit: https://i0.wp.com/grassnews.net/wp-content/uploads/2020/09/red-light-holland-reaches-distribution-agreement-for-imicrodose-packs-plus-agrees-to-build-out-an-imicrodose-media-information-centre-imic-with-super-smarts-location-in-tiel-the-netherlands.jpg?w=740&ssl=1

iMicrodose Packs powered by Red Light Holland

To view an enhanced version of this image, please visit:
https://orders.newsfilecorp.com/files/2017/64718_a8f225a094f53bdb_001full.jpg

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:
Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: todd@redlighttruffles.com
Website: https://redlighttruffles.com/

About PharmaDrug Inc.

PharmaDrug Inc., is building an international controlled substance and natural medicine company with a focus on Europe. PharmaDrug Inc., owns 80% of Pharmadrug GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU. The Company also owns 100% of Super Smart, an early-stage retail company focused on consolidating the fragmented Dutch smartshop market. Smartshops are retail establishments in The Netherlands that specialize in the sale of psychoactive substances including psychedelic truffles.

For further information, please contact:
Daniel Cohen, Chairman and CEO

dcohen@pharmadrug.co
(647) 202-1824

Forward-Looking Statements

Neither the Canadian Securities Exchange (the “CSE”) nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control.

Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward- looking statements contained herein include, but are not limited to, anticipated timeline with respect to iMicrodose products being available in Super Smart’s Store in Tiel and Red Light Holland and the anticipated timeline of the build out of the iMic, and Red Light’s plans to offer Virtual Reality Headset. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward- looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. In particular, there is no guarantee that iMicrodose products will be in Super Smart’s Tiel Location by October, 2020, nor are their guarantees that their Media Information Centre will be activated before the end of 2020. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Not for distribution to United States newswire services or for dissemination in the United States.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/64718

Continue Reading

Cannabis

MariMed Announces Participation at Canaccord Genuity’s US Cannabis Symposium on September 30, 2020

GlobeNewswire

Published

on

NORWOOD, Mass., Sept. 28, 2020 (GLOBE NEWSWIRE) — MariMed Inc. (MRMD:OTCQX) (the “Company” or “MariMed”), a leading multi-state cannabis and hemp operator focused on health and wellness, today announced that the Company’s CEO, Bob Fireman, and CFO, John Levine, will present at Canaccord Genuity’s US Cannabis Symposium on Wednesday, September 30, 2020 at 10:30 a.m. ET on Track 1.

Additionally, MariMed’s management will participate in investor meetings during the conference to discuss the Company’s consolidation strategy and growth trajectory. Investors interested in meeting with management should contact Canaccord representative Nadine Miller at nmiller@cgf.com.

Bob Fireman, Chief Executive Officer of MariMed, said, “MariMed’s growth is accelerating, as we continue to expand our adult-use consumer market share throughout the U.S. and launch innovative new products across our growing number of retail locations. We look forward to sharing some of the reasons behind our increased cannabis revenues and other recent accomplishments, at this leading industry event hosted by Canaccord.”

This one-day event will feature senior management teams representing every facet of the U.S. cannabis industry; including multi-state operators, technology providers, brand owners, hemp producers, oil extractors and ancillary products businesses.

To be added to the email distribution list, please email MRMD@kcsa.com with “MRMD” in the subject.

About MariMed:
MariMed Inc., a multi-state cannabis operator, is dedicated to improving the health and wellness of people through the use of cannabinoids and cannabis products. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. The Company is at the forefront of science and innovation through research developed by its lab technicians and medical advisors resulting in industry-leading products and brands, including “Betty’s Eddies™”, “Nature’s Heritage™”, “Bourne Baking Co.”, and “Kalm Fusion”. These precision dosed products are focused on specific symptoms and conditions and are licensed and distributed across the country.

For additional information, visit marimedinc.com.

Important Caution Regarding Forward-Looking Statements:
This release contains certain forward-looking statements and information relating to MariMed Inc. that is based on the beliefs of MariMed Inc.’s management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events, including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company’s services and products, changes in the law and its enforcement and changes in the economic environment. Additional risk factors are included in the Company’s public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as “hoped,” “anticipated,” “believed,” “planned, “estimated,” “preparing,” “potential,” “expected,” “looks” or words of a similar nature. The Company does not intend to update these forward-looking statements. None of the content of any of the websites referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company assumes no responsibility for any of such content.

All trademarks and service marks are the property of their respective owners.

Company Contact
Jon Levine, CFO
MariMed Inc.
Tel (781) 559-8713

Media Contact
Abigail Diehl
MariMed Inc.
adiehl@marimedinc.com

Annie Graf
KCSA Strategic Communications
agraf@kcsa.com

Investors
KCSA Strategic Communications
Scott Eckstein / Elizabeth Barker
MRMD@kcsa.com

Continue Reading

Cannabis

PharmaDrug’s Super Smart Reaches Distribution Agreement with Red Light Holland for iMicrodose Packs and for Red Light Holland to Build out an iMicrodose Media Information Centre (iMIC) with Super Smart’s Location in Tiel, The Netherlands

Newsfile

Published

on

Toronto, Ontario–(Newsfile Corp. – September 28, 2020) –  PharmaDrug Inc. (CSE: BUZZ) (OTC PINK: LMLLF) (“PharmaDrug” or the “Company“) is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) (“Super Smart“) has reached a distribution agreement with Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC:TRUFF) (Red Light Holland”) for Red Light Holland’s iMicrodose Packs (“iMicrodose Packs“). The iMicrodose Packs are expected to be available in Super Smart’s first Slim Winkel store, located in Tiel, in early October 2020.

Red Light Holland has also definitively agreed to build and set up an iMicrodose Media Information Centre (“iMIC”) in Super Smart’s Tiel location, expected to be ready before the end of 2020.

“Super Smart’s vision and iMicrodose’s vision truly align.” Said Todd Shapiro, CEO and Director of Red Light Holland. “Both Companies are focused on educating, informing and modernizing the psychedelic industry within the Netherlands. We are very excited to soon have another Store where our product is sold to expand our marketplace. Equally as important, we are proud to set up our first iMicrodose Media Information Centre – iMIC – where we will eventually provide Super Smart with our Virtual Reality Headset where consumers can truly learn about our iMicrodose packs and the origins of the product, as well as receive important customer feedback, as we want to give all consumer’s a voice for important information gathering and responsible use feedback via our iMIC activation.”

“Red Light Holland has definitely already taken initial steps to modernize the industry in the Netherlands and we are so pleased to house their responsible use product in our Tiel location, expected in early October 2020.” Added Daniel Cohen, CEO and Chairman of PharmaDrug. “Together we want to elevate the industry, educate consumers and intelligently target all Adult Demographics for potential increased sales via new customers with an informational, technological and modern approach.” 

Super Smart’s Tiel location is located in Central Netherlands and is the only smart shop within a 75 Kilometre radius. iMicrodose Packs powered by Red Light Holland are expected to be in Super Smart’s Tiel store in October 2020.

Cannot view this image? Visit: https://i2.wp.com/grassnews.net/wp-content/uploads/2020/09/pharmadrugs-super-smart-reaches-distribution-agreement-with-red-light-holland-for-imicrodose-packs-and-for-red-light-holland-to-build-out-an-imicrodose-media-information-centre-imic-with-super-smar.jpg?w=740&ssl=1

Pictured: iMicrodose Packs powered by Red Light Holland

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6479/64728_520c24e9846129e7_001full.jpg

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: todd@redlighttruffles.com
Website: https://redlighttruffles.com/

About PharmaDrug Inc.

PharmaDrug Inc. is building an international controlled substance and natural medicine company with a focus on Europe. The Company owns 80% of Pharmadrug GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU. The Company also owns 100% of Super Smart, an early-stage retail company focused on consolidating the fragmented Dutch smartshop market. Smartshops are retail establishments in The Netherlands that specialize in the sale of psychoactive substances including psychedelic truffles.

For further information, please contact:

Daniel Cohen, Chairman and CEO
dcohen@pharmadrug.co
(647) 202-1824

Caution Regarding Forward-Looking Information:

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED NOR DOES IT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results of the Company. Forward looking statements in this press release relate to the integration of the Smart Shop business, anticipated volume growth in the Company’s German business and the introduction by the Company of its own brand of medical cannabis. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances. The Company’s securities have not been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or “U.S. Persons”, as such term is defined in Regulations under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful. Additionally, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein, such as, but not limited to dependence on obtaining regulatory approvals; the ability to locate additional supply of medical cannabis, owning interests in companies or projects that are engaged in activities currently considered illegal under United States federal law; changes in laws; limited operating history, reliance on management, requirements for additional financing, competition, hindering market growth; regulatory and political change. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/64728

Continue Reading

Trending Online

Grassnews is part of PICANTE Media and Events, a leading media and boutique event organizer in the European Union with a monthly reach of +50,000 readers. The official company (PROSHIRT SRL), has been listed for 4 years in a row among the top 3 Advertising and market research agencies in the local Top Business Romania Microcompanies based on the Financial Reports. Grassnews digests / hand picks the latest news about the CBD / Legal Cannabis industry and serves them to you daily.

Contact us: sales@picante.today

Editorial / PR Submissions

© Grassnews .com 2019 - 2020 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania